Afoxalaner
10 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
1
Deaths Reported
1000.0%
Death Rate
Active Ingredients
Afoxalaner
Administration Routes
OralUnknown
Species Affected
Dog 10
Most Affected Breeds
Retriever - Golden 2
Retriever - Labrador 2
Catahoula Leopard Dog 2
Doberman Pinscher 1
Saint Bernard Dog 1
Bulldog - English 1
Shepherd Dog - Australian 1
Most Reported Reactions
Vomiting 4
Lethargy (see also Central nervous system depression in 'Neurological') 2
Other abnormal test result NOS 2
Eosinophilia 2
Urinary tract infection 2
Lack of efficacy (endoparasite) - heartworm 2
Elevated symmetrical dimethylarginine (SDMA) 2
Hypocortisolaemia 2
Lack of efficacy (ectoparasite) - tick NOS 2
Facial swelling (see also 'Skin') 2
Local swelling (not application site) 2
Product label issues 2
Outcome Breakdown
Outcome Unknown
6 (60.0%)
Recovered/Normal
3 (30.0%)
Died
1 (10.0%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.